Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
Observational Study in Healthy Subjects and Patients With COPD to Assess the Relationship Between Clinical, Imaging and Biomarker Measurements, and Progression of Emphysema Over Three Years [FOOTPRINTS®].
Sponsor: Boehringer Ingelheim
Listed as NCT02719184, this observational or N/A phase trial focuses on Pulmonary Disease, Chronic Obstructive and Pulmonary Emphysema and remains completed. Sponsored by Boehringer Ingelheim, it has been updated 46 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
46 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2022 — Jul 2024 [monthly]
Completed
-
Jan 2022 — Feb 2022 [monthly]
Completed
▶ Show 41 earlier versions
-
Dec 2021 — Jan 2022 [monthly]
Completed
-
Sep 2021 — Dec 2021 [monthly]
Completed
-
Jun 2021 — Sep 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2021 — Jun 2021 [monthly]
Active Not Recruiting
-
Apr 2021 — May 2021 [monthly]
Active Not Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Active Not Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Active Not Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting
-
Feb 2020 — May 2020 [monthly]
Active Not Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Active Not Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Active Not Recruiting
-
Jul 2019 — Sep 2019 [monthly]
Active Not Recruiting
-
Apr 2019 — Jul 2019 [monthly]
Active Not Recruiting
-
Feb 2019 — Apr 2019 [monthly]
Active Not Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Active Not Recruiting
-
Nov 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2018 — Mar 2018 [monthly]
Recruiting NA
-
Dec 2017 — Jan 2018 [monthly]
Recruiting NA
-
Nov 2017 — Dec 2017 [monthly]
Recruiting NA
-
Oct 2017 — Nov 2017 [monthly]
Recruiting NA
-
Sep 2017 — Oct 2017 [monthly]
Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jul 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jun 2017 — Jul 2017 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2017 [monthly]
Recruiting NA
-
Mar 2017 — Apr 2017 [monthly]
Recruiting NA
-
Jan 2017 — Mar 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .